News

Rentschler Fill Solutions inaugurates state-of-the-art fill and finish facility

Marinomed launches Initial Public Offering on the Vienna Stock Exchange

HOOKIPA Appoints Julie O’Neill as a Non-Executive Director

Arsanis Reports Financial Results for Third Quarter 2018

Themis Bioscience Postpones its Listing on Euronext Amsterdam

Valneva Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing

Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in the Lancet

EANS-News: Marinomed Biotech AG / Marinomed announces its intention to launch an Initial Public Offering and listing on the Vienna Stock Exchange

ACIB: Targeting cancer

Lexogen supports thousands of RNA researchers worldwide by partnering with the RNA Society in their 2018/19 RNA Salon initiative

Valneva Receives Positive Feedback from EMA on its further Development for Lyme Disease Vaccine VLA15

Valneva Announces Progress of Chikungunya Vaccine

Themis Bioscience Announces Exclusive Licensing Agreement with Max- Planck-Innovation to Develop and Commercialize Oncolytic Virotherapies Themis to expand measles vector immunomodulation portfolio into oncology indications

Nanocages in the lab and in the computer: how DNA-based dendrimers transport nanoparticles

TÜV AUSTRIA Wissenschaftspreis-Shortlist 2018 Die Kandidaten für den diesjährigen Wissenschaftspreis stehen fest

Award for Emmanuelle Charpentier

Roche joins the EHC PARTNERS programme

Valneva Announces FDA Approval of Accelerated IXIARO® Vaccination Schedule

Valneva Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors

Roche signs collaboration agreement to expand access to therapy information by integrating insulin data from connected pens to its open ecosystem